Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Single-Arm, Multicenter Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age

NCT03340064 is registered in ClinicalTrials.gov with UCB Japan Co. Ltd. as lead sponsor.

NCT NCT03340064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03340064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Single-Arm, Multicenter Study of Levetiracetam as Monotherapy or Adjunctive Treatment of Partial Seizures in Pediatric Epileptic Subjects Ranging From 1 Month to Less Than 4 Years of Age
Lead sponsor
UCB Japan Co. Ltd.
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2017
Completion date
July 28, 2023
Enrollment
38 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

partial seizures